DUBLIN--(BUSINESS WIRE)--Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth. is expanding its UK presence with a new office based at Manchester Science Park.
The expansion brings AscellaHealth’s specialty and rare disease pharmaceutical expertise, with offices also located in the US and Ireland, to the heart of one of the UK’s most established life sciences and biotech communities.
Dea Belazi, CEO of AscellaHealth, said, “This is exciting news for AscellaHealth and the pharmaceutical businesses who need a solution to bring emerging therapies to market.”
Bill Oldham, Chairman & President of AscellaHealth, added, “The UK’s North West region is home to a community of innovative and fast-growing science and tech businesses, so it’s the perfect base from which to support biotechs looking to streamline the commercialisation of novel specialty treatments.”
AscellaHealth supports life sciences manufacturers, payers, patients and providers – providing expertise in pre-commercialisation and market access support, distribution and fulfilment capabilities, HUB and patient support services and unique pharmaceutical financial solutions, to organisations across the globe.
This latest development follows AscellaHealth being named Best Global Specialty Pharmacy & Healthcare Services Organisation 2023 in the annual Healthcare and Pharmaceutical Awards. For more information, visit ascellahealth.eu
About AscellaHealth LLC
AscellaHealth, a global Healthcare & Specialty Pharmacy solutions company, serving patients, life sciences manufacturers, payers, and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, and a Best Global Specialty Pharmacy & Healthcare Services Organization 2023 award winner in the annual Healthcare and Pharmaceutical Awards, AscellaHealth’s best-in-class, patient-centric approach is built upon proprietary technology processes for novel programmes and services to support the launch of specialty medications and proactively address multiple challenges, optimise clinical health outcomes, and improve quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit ascellahealth.eu
